This page was translated automatically from Turkish. Read the original
This page is an AI-assisted Turkish summary of the study presented at the 26th World Congress of Psychiatry. The study belongs to the presenting authors; please refer to the original source when citing it.
EV0466
Artificial intelligence in psychiatry: clinical applications, diagnostic advances, and ethical issues
ARTIFICIAL INTELLIGENCE IN PSYCHIATRY: CLINICAL APPLICATIONS, DIAGNOSTIC ADVANCES, AND ETHICAL CHALLENGES
Presenter: Pedro Henrique Pianta
Country: Brazil
Artificial intelligence can enhance psychiatric diagnosis and continuous monitoring, but its clinical value depends on validation, equity, ethical oversight, and ongoing clinician involvement.
The aim is to examine how artificial intelligence (AI) is currently used in psychiatric diagnosis and to discuss its clinical significance, performance, and key challenges for individual care and community mental health. The method is a narrative review based on publications from 2015 to 2025 retrieved through PubMed, Google Scholar, and SciELO. The reviewed literature suggests that AI-based approaches have the potential to support earlier recognition of symptoms, continuous monitoring, and, in some settings, prediction of the course of illness, with some studies reporting diagnostic accuracy between 80% and 85%. Clinical applications include pattern recognition through machine learning in diagnosis; symptom tracking using wearable devices in monitoring; chatbots for treatment support and AI tools to improve screening and accessibility; models that estimate the risk of relapse and predict illness course; and, in public health, the identification of at-risk populations and resource planning. Examples include speech analysis, wearable devices, chatbot-based tools, and digital phenotyping. The discussion highlights a gap between technological development and real-world clinical practice, noting that the growing use of these technologies outside clinical settings raises questions about safety, reliability, self-diagnosis, and the changing physician–patient relationship. The main clinical and ethical challenges are grouped under data variability, limited generalizability, algorithmic bias and digital inequality, privacy, autonomy and accountability, and inappropriate self-management. In conclusion, AI has the potential to enhance psychiatric diagnosis and care, but its role should remain complementary to clinical judgment and be supported by validation, ethical oversight, and clinician involvement.
View the original posterHow to cite this study
APA 7: Pianta, P. H., & Leal, J. F. (2026, September 23-26). Artificial intelligence in psychiatry: clinical applications, diagnostic advances, and ethical challenges [E-poster]. 26th WPA World Congress of Psychiatry (WCP 2026), Stockholm, Sweden. https://cslide.ctimeetingtech.com/wcp26/attendee/eposter/file/799
Vancouver: Pianta PH, Leal JF. Artificial intelligence in psychiatry: clinical applications, diagnostic advances, and ethical challenges [e-poster]. 26th WPA World Congress of Psychiatry (WCP 2026); 2026 Sep 23-26; Stockholm, Sweden. Available from: https://cslide.ctimeetingtech.com/wcp26/attendee/eposter/file/799
Author names and title formatting were generated automatically from the congress system; please check them against the original poster before use.
On the same topic
- Siber tanıkların davranışını belirleyen etkenler
- Z kuşağında sosyal medyanın "lunapark etkisi"nin modellenmesi: örtük değişken yaklaşımı
- DEHB'de dijital girişimler: etkililik ve çok modlu tedavi yaklaşımlarına entegrasyon
- Algoritmaların inşa ettiği beyinler: dijital çağda DEHB, patolojiyi mi tanılıyoruz yoksa yeni bir normali mi patolojikleştiriyoruz?
- Genç erişkin bir örneklemde nomofobi ile yaygın anksiyete bozukluğu arasındaki ilişki